OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 25, 2005
Bavarian Nordic Sues Acambis for Patent Infringement
August 18, 2005
Acambis and Bavarian Nordic Vie for Smallpox Vaccine Contract
August 11, 2005
GSK Releases Flu Vaccine Production Strategies
US Government Orders 2M Doses of Avian Flu Vaccine
August 02, 2005
Being the first to gain the most is a fundamental principle in the generics business because several companies compete to create generics of successful products going off patent. For a generics company to maintain revenue growth in a market in which product prices continue to fall, it must secure a continuous flow of new products, with quality and speed to market being key drivers. Thus, generics companies must be highly skilled in product and process development (1), the generics business, and achieving bioequivalence-the most critical development area.
August 01, 2005
Various systems and measures can be used to safely handle and process explosive pharmaceutical compounds in a range of manufacturing procedures.
The aim of this study was to analyse the process of tablet formation and the properties of the final tablets for six different carrageenans. The carrageenans used were based on the basic types of ?-, ?- and ?-carrageenan. Microcrystalline cellulose was used for comparison. Determination of material properties, compression analysis and tablet properties were described. Water content, particle size and morphology, glass transition temperature, and crystallinity were studied. The results show that the carrageenans are predominantly amorphous fibres, which are in the rubbery state during tabletting.
July 29, 2005
Microbioreactor Array System Boost Cell Culture Capacity
Protein Refolding Technology Improves Yields
July 21, 2005
Able Labs Files for Chapter 11